Human TNFRSF1A (TNF Receptor I) knockout HeLa cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
TNFRSF1A KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 2 and 2 bp deletion in exon 2.
View Alternative Names
CD120a, FPF, MGC19588, P60, TBP-1, TBPI, TNF R, TNF R55, TNF-R1, TNFAR, TNFR-I, TNFR60, TNR1A_HUMAN, Tumor necrosis factor receptor 1, Tumor necrosis factor receptor superfamily, member 1A, Tumor necrosis factor receptor type 1, Tumor necrosis factor receptor type I, Tumor necrosis factor-binding protein 1, p55, p55-R
- WB
Lab
Western blot - Human TNFRSF1A (TNF Receptor I) knockout HeLa cell lysate (AB257751)
All lanes : Anti-TNF Receptor I antibody [EPR23742-65] (ab259817) at 1/1000 dilution
Lane 1 : Wild-type HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate
Lane 2 : TNFRSF1A (TNF Receptor I) knockout HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate
Lane 3 : A549 (human lung carcinoma epithelial cell) whole cell lysate
Lysates/proteins at 20 μg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (IRDye® 800CW) (ab216773) and Goat Anti-Mouse IgG H&L (IRDye® 680RD) (ab216776) at 1/10000 dilution
Predicted band size : 50 kDa
Observed band size : 50-70 kDa
Blocking and diluting buffer and concentration : 3% NFDM/TBST
Lanes 1-3 : Merged signal (red and green). Green - ab259817 observed at 51 kDa. Red - loading control ab8245 (Mouse monoclonal [6C5] to GAPDH) observed at 36 kDa.
ab259817 Anti-TNF Receptor I antibody [EPR23742-65] was shown to specifically react with TNF Receptor I in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265972 (knockout cell lysate ab257751) was used. Wild-type and TNF Receptor I knockout samples were subjected to SDS-PAGE. ab259817 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated at 4°C overnight at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-TNF Receptor I antibody [EPR23742-65] (<a href='/en-us/products/primary-antibodies/tnf-receptor-i-antibody-epr23742-65-ab259817'>ab259817</a>) at 1/1000 dilution
Lane 1:
Wild-type HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
TNFRSF1A (TNF Receptor I) knockout HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
Western blot - Human TNFRSF1A (TNF Receptor I) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-tnfrsf1a-tnf-receptor-i-knockout-hela-cell-line-ab265972'>ab265972</a>)
Lane 3:
A549 (human lung carcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG H&L (IRDye® 800CW) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) and Goat Anti-Mouse IgG H&L (IRDye® 680RD) (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/10000 dilution
Predicted band size: 50 kDa
Observed band size: 50-70 kDa
false
- WB
Lab
Western blot - Human TNFRSF1A (TNF Receptor I) knockout HeLa cell lysate (AB257751)
Lane 1 : Wild-type HeLa cell lysate 20 μg
Lane 2 : HeLa cell lysate 20 μg
False colour image of Western blot : Anti-TNFRSF1A antibody staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, the antibody was shown to bind specifically to TNFRSF1A. A band was observed at 33/63 kDa in wild-type HeLa cell lysates with no signal observed at this size in TNFRSF1A knockout cell line ab265972 (knockout cell lysate ab257751). To generate this image, wild-type and TNFRSF1A knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Anti-TNFRSF1A antibody at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human TNFRSF1A (TNF Receptor I) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-tnfrsf1a-tnf-receptor-i-knockout-hela-cell-line-ab265972'>ab265972</a>)
false
- WB
Lab
Western blot - Human TNFRSF1A (TNF Receptor I) knockout HeLa cell lysate (AB257751)
Lane 1 : Human wild-type HeLa cell lysate
Lane 2 : Human TNFRSF1A knockout HeLa cell lysate
Lane 3 : Human brain cell lysate
Lane 4 : HL-60 cell lysate
Lanes 1-4 : Merged signal (red and green). Green - anti-TNF-R1 Rabbit monoclonal antibody observed at 51 kDa. Red - loading control, ab8245 observed at 36 kDa.
Anti-TNF-R1 Rabbit monoclonal antibody and anti-GPADH antibody [6C5] - Loading control (ab8245) were incubated overnight at 4oC at a 1/1000 and 1/20000 dilution respectively before imaging. Blots were developed with Goat anti-Rabbig IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10,000 dilution for 1 hour at room temperature before imaging.
All lanes:
Anti-TNF-R1 Rabbit monoclonal antibody at 1/1000 dilution
Lane 1:
Human wild-type HeLa cell lysate
Lane 2:
TNFRSF1A knockout HeLa cell lysate
Lane 2:
Western blot - Human TNFRSF1A (TNF Receptor I) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-tnfrsf1a-tnf-receptor-i-knockout-hela-cell-line-ab265972'>ab265972</a>)
Lane 3:
Human brain cell lysate
Lane 4:
HL-60 cell lysate
false
- Sanger seq
Unknown
Sanger Sequencing - Human TNFRSF1A (TNF Receptor I) knockout HeLa cell lysate (AB257751)
Allele-1 : 2 bp deletion in exon 2
- Sanger seq
Unknown
Sanger Sequencing - Human TNFRSF1A (TNF Receptor I) knockout HeLa cell lysate (AB257751)
Allele-2 : 1 bp deletion in exon 2
Reactivity data
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com